American Society For Pharmacology And Experimental Therapeutics Inc is located in Rockville, MD. The organization was established in 1938. As of 12/2021, American Society For Pharmacology And Experimental Therapeutics Inc employed 20 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. American Society For Pharmacology And Experimental Therapeutics Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, American Society For Pharmacology And Experimental Therapeutics Inc generated $7.6m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 6.3% each year. All expenses for the organization totaled $4.7m during the year ending 12/2021. While expenses have increased by 0.8% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2014, American Society For Pharmacology And Experimental Therapeutics Inc has awarded 152 individual grants totaling $1,709,841. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (ASPET) IS A 4,000 MEMBER SCIENTIFIC SOCIETY WHOSE MEMBERS CONDUCT BASIC AND CLINICAL PHARMACOLOGICAL RESEARCH AND WORK FOR ACADEMIA, GOVERNMENT, LARGE PHARMACEUTICAL COMPANIES, SMALL BIOTECH COMPANIES, AND NON-PROFIT ORGANIZATIONS.
Describe the Organization's Program Activity:
PUBLICATIONS - THE SOCIETY PUBLISHES SCIENTIFIC AND EDUCATIONAL JOURNALS AND OTHER PUBLICATIONS FOR THE SCIENTIFIC COMMUNITY INCLUDING THE FOLLOWING:JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS - MONTHLY RESEARCH PUBLICATION COVERING TOPICS INCLUDING THE INTERACTIONS OF CHEMICALS WITH BIOLOGICAL SYSTEMS, INCLUDING AUTONOMIC, BEHAVIORAL, CARDIOVASCULAR, CELLULAR, CLINICAL, DEVELOPMENTAL, GASTROINTESTINAL, IMMUNO-, NEURO-, PULMONARY AND RENAL PHARMACOLOGY, AS WELL AS ANALGESICS, DRUG ABUSE, METABOLISM AND DISPOSITION, CHEMOTHERAPY, AND TOXICOLOGY.PHARMACOLOGICAL REVIEWS - QUARTERLY REVIEW JOURNAL COVERING CONCENTRATIONS IN PHARMACOLOGY, EXPERIMENTAL THERAPEUTICS, TOXICOLOGY, AND CHEMOTHERAPY.MOLECULAR PHARMACOLOGY - MONTHLY PUBLICATION WITH AN EMPHASIS ON RESEARCH OF DRUG ACTION AND SELECTIVE TOXICITY AT THE MOLECULAR LEVEL. ORIGINAL APPLICATIONS OF BIOCHEMISTRY, BIOPHYSICS, GENETICS AND MOLECULAR BIOLOGY ARE COMBINED WITH PHARMACOLOGIC RESEARCH TO SOLVE BASIC PROBLEMS IN PHARMACOLOGY AND TOXICOLOGY.DRUG METABOLISM AND DISPOSITION - MONTHLY PUBLICATION COVERING THE FIELDS OF PHARMACOKINETICS, PHARMACODYNAMICS AND MECHANISMS, GENETIC NUTRITIONAL OR HORMONAL FACTORS AFFECTING THE BIOLOGICAL FATE OF CHEMICALS, AND THE TOXICOLOGICAL CONSEQUENCES OF XENOBIOTIC METABOLISM. THE PHARMACOLOGIST - QUARTERLY PUBLICATION WITH THE PURPOSE OF INFORMING PHARMACOLOGISTS ABOUT SOCIETY AFFAIRS AND OTHER MATTERS OF PROFESSIONAL INTEREST. DISTRIBUTED ELECTRONICALLY TO ASPET MEMBERS AND MAILED TO NONMEMBER SUBSCRIBERS AS WELL AS MEMBERS WHO PAY FOR A PRINT SUBSCRIPTION.
MEMBER SERVICES - DIVISIONS ADDRESS SPECIFIC AREAS OF CONCERN OR INTEREST TO THE MEMBER PHARMACOLOGISTS IN THE SOCIETY. NOMINATION AND ELECTION OF NEW MEMBERS, DEVELOPMENT OF EDUCATIONAL ACTIVITIES RELEVANT TO THE PROMOTION AND ADVANCEMENT OF THE SCIENTIFIC DISCIPLINE. WEB SITE PROVIDES AN INTERFACE BETWEEN MEMBERS AND THE SOCIETY AS WELL AS INFORMATION TO INDIVIDUALS WISHING TO LEARN MORE ABOUT THE FIELD OF PHARMACOLOGY.
MEETINGS - THE SOCIETY PARTICIPATES IN A SPRING MEETING EACH YEAR PROVIDING A FORUM FOR SCIENTISTS TO COMMUNICATE AND EXCHANGE PHARMACOLOGICAL KNOWLEDGE THROUGH SCIENTIFIC SESSIONS. SMALLER FOCUSED MEETINGS ARE HELD ON AN OCCASIONAL BASIS AS THE NEED ARISES.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Judith Siuciak Executive Director | Officer | 40 | $496,753 |
Matthew Hilliker Chief Financial Officer | Officer | 40 | $154,828 |
Melissa Huston Meetings Director | 40 | $130,860 | |
Catherine Fry Education Director | 40 | $123,393 | |
Suzie Thompson Director Of Marketing | 40 | $122,752 | |
Maria Pasho Publications Director | 40 | $106,257 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Dartmouth Journal Services Journal Production | 12/30/21 | $320,593 |
Mps Limited Online Peer Review And Online Journals | 12/30/21 | $253,478 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $350,502 |
All other contributions, gifts, grants, and similar amounts not included above | $44,416 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $394,918 |
Total Program Service Revenue | $3,944,842 |
Investment income | $513,148 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $2,321,639 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $7,613,751 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $189,000 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $700,173 |
Compensation of current officers, directors, key employees. | $88,904 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $1,382,534 |
Pension plan accruals and contributions | $128,867 |
Other employee benefits | $255,254 |
Payroll taxes | $131,791 |
Fees for services: Management | $0 |
Fees for services: Legal | $8,505 |
Fees for services: Accounting | $37,350 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $149,739 |
Fees for services: Other | $692,762 |
Advertising and promotion | $32,862 |
Office expenses | $58,133 |
Information technology | $146,357 |
Royalties | $0 |
Occupancy | $189,019 |
Travel | $78,964 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $16,991 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $69,579 |
Insurance | $42,969 |
All other expenses | $0 |
Total functional expenses | $4,699,167 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,694,703 |
Savings and temporary cash investments | $316,558 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $254,226 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $119,203 |
Net Land, buildings, and equipment | $324,301 |
Investments—publicly traded securities | $31,184,159 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $33,893,150 |
Accounts payable and accrued expenses | $570,212 |
Grants payable | $0 |
Deferred revenue | $1,253,066 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $56,766 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $514,381 |
Total liabilities | $2,394,425 |
Net assets without donor restrictions | $28,852,454 |
Net assets with donor restrictions | $2,646,271 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $33,893,150 |
Over the last fiscal year, American Society For Pharmacology And Experimental Therapeutics Inc has awarded $189,000 in support to 17 organizations.
Grant Recipient | Amount |
---|---|
Piscataway, NJ PURPOSE: INSTITUTIONAL SURF AWARD | $18,000 |
Chapel Hill, NC PURPOSE: INSTITUTIONAL SURF AWARD | $18,000 |
UNIVERSITY OF NORTH DAKOTA PURPOSE: INSTITUTIONAL SURF AWARD | $18,000 |
UNIVERSITY OF ARIZONA PURPOSE: INSTITUTIONAL SURF AWARD | $18,000 |
Durham, NC PURPOSE: INSTITUTIONAL SURF AWARD | $9,000 |
Urbana, IL PURPOSE: INSTITUTIONAL SURF AWARD | $9,000 |
Over the last fiscal year, we have identified 1 grants that American Society For Pharmacology And Experimental Therapeutics Inc has recieved totaling $104.
Awarding Organization | Amount |
---|---|
Amazonsmile Foundation Seattle, WA PURPOSE: GENERAL SUPPORT | $104 |
Beg. Balance | $1,573,400 |
Earnings | $235,683 |
Grants | $176,055 |
Ending Balance | $1,633,028 |
Organization Name | Assets | Revenue |
---|---|---|
American Association Of Colleges Of Pharmacy Arlington, VA | $14,816,007 | $11,822,520 |
American Association Of Pharmaceutical Scientists Arlington, VA | $17,272,832 | $11,114,261 |
American Society For Pharmacology And Experimental Therapeutics Inc Rockville, MD | $33,893,150 | $7,613,751 |
American Society For Clinical Pharmacology & Therapeutics Alexandria, VA | $5,298,284 | $2,105,682 |
American Pharmacists Association Foundation Washington, DC | $7,176,985 | $2,699,027 |
Josephs House Inc Financial Office Washington, DC | $1,561,380 | $1,670,495 |
Virginia Pharmaceutical Assoc Research Education Foundation Inc North Chesterfield, VA | $1,278,081 | $50,734 |
Pharmacy Manpower Project Inc Arlington, VA | $104,674 | $0 |
International Society Of Regulatory Toxicology And Pharmacology Washington, DC | $78,418 | $0 |